GENE ONLINE|News &
Opinion
Blog

2024-09-02| Asia-Pacific

Core8 Australia, Truongson, and Him Lam Form VIEH Singapore to Drive Investment in Vietnam’s Duc Hoa 3 Industrial Park

by Bernice Lottering
Share To
Him Lam JSC and Truongson Land JSC, in collaboration with Core8 Information Australia Pty Ltd, have formed VIEH Singapore with the aim of transforming Duc Hoa 3 Industrial Park into a high-tech hub for the biotech and semiconductor industries, attracting global leaders and fostering innovation in Vietnam.

Him Lam JSC (Him Lam), Truongson Land JSC (Truongson Land) and Core8 Information Australia Pty Ltd (Core8) with VIEH Singapore have joined forces to enhance Duc Hoa 3 Industrial Park (IP) in Long An province, Vietnam. This collaboration aims to transform the 700-hectare park into a key destination for the biotech and semiconductor industries, attracting global leaders and fostering future innovation in the region.

Vietnam Positions Itself as a Hub for High-tech Industry Advancements

The partnership aims to leverage Core8 Australia‘s expertise in high-tech and biotech sectors, along with VIEH Singapore’s international network, to attract major semiconductor and biotechnology companies, particularly from Taiwan. The goal is to establish Duc Hoa 3 IP as a premier site for these industries, offering access to Vietnam’s growing market.

Duc Hoa 3 IP, strategically located near Ho Chi Minh City, benefits from modern infrastructure and excellent transport links, including proximity to ports, airports, and the Moc Bai border gate. This location supports the establishment of new operations and provides easy access to a skilled workforce.

Leveraging Core8 Australia’s global network and expertise in biotech and high-tech industries, alongside Him Lam and Truongson Land’s operational assets, the partnership aims to attract leading investors and manufacturers. The goal is to position Duc Hoa 3 IP as a premier destination for semiconductor and biotechnology companies, capitalizing on the region’s growth opportunities.

The collaboration presents exciting new prospects for VIEH to engage with international stakeholders and enhance its global footprint. Through the integration of real estate development and technological advancements, the partnership establishes a strong ecosystem for key players in the industry.

Him Lam, Truongson Land and Core8 Australia, with VIEH Singapore are committed to upholding the highest standards of sustainability and corporate responsibility. The development of Duc Hoa 3 IP will include advanced facilities and a supportive investment climate, making it an attractive destination for global companies seeking to expand in Vietnam. This strategic partnership represents a significant milestone in shaping Vietnam’s industrial landscape and driving future investment and innovation.

By integrating real estate development with technology innovation, the partnership aims to build a robust ecosystem that encourages knowledge transfer and cross-border partnerships among industry leaders.

 

By integrating real estate development with technology innovation, the partnership aims to build a robust ecosystem that encourages knowledge transfer and cross-border partnerships among industry leaders.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Thai Biotech Industry’s Promising Potential: Taiwan Works Toward Strengthening APAC Ties at Bio Asia Pacific—Collaboration is Key
2024-09-24
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
LATEST
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
Scroll to Top